Can I Take Antibiotics Before Cataract Surgery?

Understand how oral antibiotics, prophylactic drops, and active infections impact your cataract surgery timeline and preparation protocol.

Antibiotics are a standard part of cataract surgery, but the answer to whether you should take them before the procedure depends on what kind of antibiotic, and how it reaches your eye. Most surgeons prescribe antibiotic eye drops in the days leading up to surgery, yet the strongest evidence for preventing infection actually points to antibiotics injected directly into the eye during the operation itself. Oral antibiotics, the kind you might think of when you hear “take antibiotics,” are a different story entirely and are rarely necessary. The distinction between these routes matters far more than most patients realize.

The Infection Antibiotics Are Meant to Prevent

The primary worry behind every antibiotic protocol in cataract surgery is endophthalmitis, a rare but serious infection inside the eye. Even with modern sterile techniques, bacteria from the eyelid skin, tear film, or conjunctiva can enter the eye during the procedure. Endophthalmitis occurs in roughly 3 out of every 10,000 cataract surgeries when preventive measures are in place, but untreated it can lead to permanent vision loss. That low rate is itself the product of decades of refining antiseptic and antibiotic protocols. The question for you as a patient is not whether to use antibiotics at all, but which method gives the best protection with the least downside.

Intracameral Antibiotics Have the Best Track Record

The antibiotic approach with the most robust evidence is intracameral injection, where the surgeon delivers a small dose of antibiotic (usually cefuroxime or moxifloxacin) directly into the front chamber of the eye at the end of the operation. A review of clinical guidelines found that intracameral antibiotics for infection prevention were among the most consistently recommended practices, supported by high-level evidence. A systematic review and meta-analysis found high-to-moderate quality evidence for a marked reduction in endophthalmitis risk with intracameral cefazolin, cefuroxime, and moxifloxacin.

The size of the benefit is striking. One review estimated that intracameral antibiotics reduced endophthalmitis roughly 3.5-fold compared to no intracameral injection. Another large study found intracameral antibiotic was more effective than topical drops alone. This is the antibiotic that matters most in cataract surgery, and it is administered by the surgeon, not something you take at home.

Topical Antibiotic Eye Drops Before Surgery

Despite being widely prescribed, antibiotic eye drops used in the days before surgery have a surprisingly thin evidence base when it comes to actually preventing endophthalmitis. Many ophthalmologists ask patients to use fluoroquinolone drops (moxifloxacin, gatifloxacin, or levofloxacin) for one to three days before the procedure, and practice varies substantially from country to country. The logic is straightforward: reduce the bacterial population on the eye’s surface before the surgeon cuts into it.

However, the evidence that preoperative drops alone prevent infection is weak. A Cochrane review found an uncertain effect when topical levofloxacin was used alone compared with placebo. That same systematic review and meta-analysis that endorsed intracameral antibiotics found no evidence that topical antibiotics by themselves prevent endophthalmitis. An older study also found no significant difference in endophthalmitis rates between patients who used preoperative antibiotic drops and those who did not.

A cost-effectiveness analysis put it bluntly: the tiny absolute risk reduction from preoperative topical antibiotic drops (about 0.008 percentage points) made them not cost-effective at typical drug prices, and they would only become worthwhile at a drug cost under $0.75 or an endophthalmitis rate above 5.5%, a rate far higher than what occurs in modern practice.

So why do surgeons still prescribe them? Partly habit, partly the theoretical benefit of reducing surface bacteria even if that hasn’t translated into measurable infection prevention in trials, and partly because combining them with intracameral antibiotics is the standard in many regions. The study comparing strategies found that adding topical drops to an intracameral injection did not produce better results than the injection alone. If your surgeon prescribes preoperative drops, it is reasonable to use them as directed, but understand that the injection during surgery is doing most of the heavy lifting.

Oral Antibiotics Are Usually Unnecessary

If you are wondering whether you need to swallow a pill before cataract surgery, the answer is almost always no. A retrospective study reviewing consecutive cataract surgeries performed under local anesthesia found zero surgical site infections regardless of whether patients received systemic (oral) antibiotics, as long as topical drops and povidone-iodine irrigation were used. Oral antibiotics carry their own risks, including gut disruption and allergic reactions, without adding meaningful protection to an already effective local protocol. The clinical guidelines reviewed across multiple countries echo this: routine preoperative systemic tests and interventions are generally unnecessary for cataract surgery under local anesthesia.

There are rare exceptions. Patients with certain systemic infections or immunocompromised conditions may receive oral antibiotics for other medical reasons around the time of surgery. But as a blanket measure to prevent eye infections from cataract surgery, oral antibiotics have no established role.

Povidone-Iodine Is the Unsung Hero

Before any antibiotic enters the equation, almost every cataract surgery worldwide begins with povidone-iodine, an antiseptic solution applied to the eye and surrounding skin. This step has been part of cataract surgery protocols since the 1980s and is considered a cornerstone of infection prevention. A 5% povidone-iodine solution applied for just three minutes dramatically cuts the number of bacteria on the eye’s surface, reducing culture-positive swabs from 87% to 30% in one study. Even a low-concentration povidone-iodine depot device placed in the lower eyelid pocket completely eliminated bacteria in about two-thirds of colonized participants.

Unlike antibiotics, povidone-iodine works broadly against bacteria, viruses, and fungi without promoting resistance. Some researchers argue it does more for infection prevention than preoperative antibiotic drops. If you have an iodine allergy, your surgeon will use an alternative antiseptic, but for the vast majority of patients, this brief antiseptic wash is a crucial part of the safety protocol and happens in the operating room, not something you need to do at home.

Antibiotic Resistance and Why Shorter Courses Matter

One genuine concern with prescribing antibiotic eye drops around cataract surgery is the development of resistant bacteria on the eye’s surface. Research has shown that even three weeks of topical levofloxacin (a common fluoroquinolone) selects for resistant bacteria on the eye. A study tracking the long-term effects found that after a standard course of topical levofloxacin, the bacteria that remained on the eye had significantly higher resistance levels, and those levels did not return to baseline until six to twelve months later.

The good news is that shorter courses seem to cause less lasting damage. Patients who used levofloxacin for just one week postoperatively saw their normal eye flora recover faster than those who used it for a month. A systematic review looking specifically at whether resistance patterns in endophthalmitis-causing organisms are changing found that while longer antibiotic use might increase resistance, the difference did not persist beyond six months. The practical takeaway: if your surgeon prescribes drops, use them for exactly the duration recommended and not longer. There is no benefit to extending the course on your own, and real potential for harm.

Another factor in resistance is the preservative benzalkonium chloride, which is present in many eye drop formulations. Prolonged exposure to drops containing this preservative was associated with a higher incidence of bacteria resistant to both methicillin and fluoroquinolones. If you are using multiple eye drops for other conditions like glaucoma, mentioning that to your surgeon could be relevant.

Safety of Antibiotics Applied to the Eye

Patients sometimes worry about whether antibiotics used on or inside the eye can cause damage. Fluoroquinolones, aminoglycosides, and several other drug classes can cause corneal toxicity in some patients when applied topically. However, lab testing on corneal endothelial cells found that the antibiotics commonly used after cataract surgery are unlikely to cause damage at the concentrations used under normal conditions. Among the antibiotics tested, cefmenoxime showed the least toxicity, while moxifloxacin showed the most, though none reached harmful levels in typical use. The preservatives in the drops, particularly benzalkonium chloride, may contribute more to irritation than the antibiotic itself.

For intracameral injection, safety data across large studies has been reassuring. The doses used are small and confined to the anterior chamber, and reviews have substantiated both the safety and efficacy of this approach. Rare adverse effects have been reported, typically linked to compounding errors in preparing the injection rather than inherent toxicity of the drug at the correct dose.

When the Protocol Changes for Higher-Risk Patients

Not every patient gets the same antibiotic regimen. Surgeons adjust their approach for people with conditions that raise infection risk. In one study, patients with chronic blepharitis (inflamed eyelids), conjunctivitis, lacrimal system disease, or systemic conditions like autoimmune or skin disorders had conjunctival swabs taken before surgery. If bacteria were found, targeted antibiotic treatment was given before the operation, and surgery was only performed once repeat cultures came back negative.

This is a different scenario from the routine “take these drops three times a day for two days before surgery” instruction that most patients receive. If you have any chronic eye conditions, diabetes, or are on immunosuppressive medications, your surgeon may order cultures, adjust the antibiotic choice based on sensitivity testing, or delay surgery until the eye’s bacterial load is controlled. This is one situation where preoperative antibiotics genuinely earn their place, because the baseline risk is higher.

Lid Hygiene as a Complementary Step

An underappreciated aspect of preoperative preparation is simple eyelid cleaning. A study evaluating antiseptic eyelid wipes used for several days before surgery found they reduced eyelid bacterial load by about 58% to 63%, with a roughly 70% reduction in conjunctival bacteria as well. The degree of reduction was comparable to what other studies achieved with topical antibiotic drops. Some surgeons now recommend lid wipes or dilute baby shampoo scrubs in the days before surgery as a complementary measure, especially for patients with oily eyelids or blepharitis. It is a low-risk, low-cost step you can take at home that directly addresses the source of most contaminating bacteria.

Why Practices Vary So Much Around the World

If you research this topic online or talk to friends who have had cataract surgery in different countries, you will find wildly different protocols. Some patients are given antibiotic drops for three days before surgery and two weeks after. Others get a single injection during the procedure and nothing else. Surveys of practice patterns confirm there is no universal consensus on the preoperative, intraoperative, and postoperative antibiotic regimen.

In Europe, particularly Scandinavia and the UK, intracameral cefuroxime has been standard for years, often with minimal topical drops. In the United States, topical fluoroquinolone drops both before and after surgery remain dominant, partly because no commercially prepared intracameral antibiotic product was available until recently (surgeons had to compound their own). In parts of Asia, approaches vary institution by institution. These differences are driven more by regulatory environments, drug availability, and surgical tradition than by conflicting evidence. The evidence itself is fairly consistent: intracameral antibiotics provide the clearest benefit.

Practical Tips for Using Eye Drops Correctly

If your surgeon does prescribe preoperative antibiotic drops, getting them into your eye properly matters more than you might expect. Noncompliance with prescribed eye drops is a common issue in cataract surgery patients, and poor technique can undermine whatever benefit the drops might provide. The most important points are keeping the bottle tip from touching your eye, eyelashes, or skin, and following the prescribed schedule. A pilot study evaluating drop bottle contamination in clinical settings found that when instillation was done with proper training and technique, no contact between the bottle tip and the eye occurred and contamination rates from the drops themselves were low.

A few techniques help: tilt your head back, pull down your lower eyelid to create a small pocket, and let the drop fall into the pocket without squeezing too hard. If you struggle with hand tremor or coordination, ask about assistive devices or have a family member help. Skipping doses or using the drops inconsistently is worse than not using them at all, because it delivers a subtherapeutic antibiotic exposure that promotes resistance without reducing bacterial counts meaningfully.

The Cost Question

For patients paying out of pocket or facing high copays, the economics of different antibiotic strategies are worth knowing. As noted, preoperative topical antibiotic drops are not cost-effective at typical drug prices for preventing endophthalmitis. Intracameral moxifloxacin, by contrast, was found to be cost-saving from a societal perspective compared to traditional topical-only prophylaxis, and cost-effective from a healthcare sector perspective. The intracameral approach was especially cost-saving in cases where a complication called a posterior capsule tear occurred during surgery, since that complication raises infection risk substantially.

This does not mean you should refuse to fill your drop prescription to save money. Your surgeon’s protocol accounts for your specific situation, and the drops may serve other roles (reducing inflammation, preventing other complications). But if you are ever in a position to discuss options with your surgeon, knowing that the injection during surgery carries the strongest evidence and the best cost profile can make that conversation more productive.

How Fluoroquinolone Drops Differ From Each Other

If you are prescribed eye drops, you may see names like moxifloxacin, gatifloxacin, or levofloxacin. These are all fluoroquinolone antibiotics, but they are not identical in how well they penetrate the eye. In a study measuring drug levels inside the eye’s aqueous humor after standard preoperative dosing, moxifloxacin achieved roughly five times the concentration of gatifloxacin. Despite that pharmacological difference, both drugs produced similar reductions in eyelid and conjunctival bacterial counts and equally low rates of aqueous contamination after surgery. In practice, whichever fluoroquinolone your surgeon chooses is likely adequate for surface decontamination. The differences in aqueous penetration matter more when considering intracameral use, which is one reason moxifloxacin has become the preferred intracameral agent in many settings.